TMO EPM / Hemato H9J cover art

TMO EPM / Hemato H9J

TMO EPM / Hemato H9J

Written by: TMO EPM / Hemato H9J
Listen for free

About this listen

 Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASATMO EPM / Hemato H9J Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • 68 - Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    68 - Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Jan 11 2026

    Discussão do artigo: "Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia" de Kantarjian H JCO 2024

    Apresentado por: Dr. Matheus Garcia

    Discussão por: Dr. Eduardo Burlamaqui , Dra. Ilana Barcessat, Dra. Amanda Chucre, Dr. Pedro Moraes e Dr. Vinícius Molla
    Show More Show Less
    33 mins
  • 67 - Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

    67 - Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
    Jan 7 2026

    Discussão do artigo: "Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma" de Jagannath S JCO 2025

    Apresentado por: Dr. Guilherme Rodrigues

    Discussão por: Dr. Eduardo Burlamaqui, Dra. Ana Cecilia Bahia, Dr. Pedro Moraes e Dr. Vinícius Molla
    Show More Show Less
    24 mins
  • 66 - Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study

    66 - Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
    Dec 30 2025

    Discussão do artigo: "Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study" de Chavez J blood 2025

    Apresentado por: Dra. Ilana Barcessat

    Discussão por: Dr. Rafael Faust , Dra. Ana Cecilia Bahia, Dr. Pedro Moraes e Dr. Vinícius Molla
    Show More Show Less
    27 mins
No reviews yet